Clinical Trials Directory

Trials / Completed

CompletedNCT01419145

A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
46 (actual)
Sponsor
Norwegian University of Science and Technology · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

A multicentre, open, randomized phase II study comparing a multimodal intervention (oral nutritional supplements, celecoxib and physical exercise) for cachexia versus standard cancer care.

Conditions

Interventions

TypeNameDescription
OTHERMultimodal interventionNutritional supplements aimed at optimal energy balance and protein intake (2 cartons of ProSure per day), nutritional advice, home-based self-assisted exercise program and anti-inflammatory treatment (300 mg celecoxib) for 6 weeks. The aerobic exercise program is performed as self-administered daily walking sessions, aiming for a minimum of two sessions 30 minutes on a weekly basis. Other aerobic activities could be used instead of walking. The resistance exercise program should be performed 3 times weekly and lasts about 20 minutes. The program is targeting major muscle groups in the upper body and legs with use of weights. The intensity of the exercise and performance of the exercises are adapted to the individual patient's disease burden and physical performance.
OTHERStandard careStandard cancer care

Timeline

Start date
2011-10-01
Primary completion
2014-08-01
Completion
2014-11-01
First posted
2011-08-17
Last updated
2017-06-16

Locations

3 sites across 2 countries: Norway, United Kingdom

Source: ClinicalTrials.gov record NCT01419145. Inclusion in this directory is not an endorsement.